| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Johnson & Johnson is a 10% Owner at NERV with holdings across 4 companies. Recent SEC Form 4 filings include 2 buys and 11 sells.
Estimated insider holdings value: $1208.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | JNJ Johnson & Johnson | 10% Owner | Sell | 6,337 | $10.03 | $63,560.11 | -0.2% | +18.7% | - | |
| Nov 24, 2025 | JNJ Johnson & Johnson | 10% Owner | Sell | 2,700 | $10.05 | $27,132.00 | - | +19.3% | - | |
| Nov 12, 2025 | JNJ Johnson & Johnson | 10% Owner | Sell | 1,000 | $10.00 | $10,000.00 | - | +22.6% | - | |
| Nov 7, 2025 | JNJ Johnson & Johnson | 10% Owner | Sell | 52,532 | $10.21 | $536,309.72 | -0.6% | +27.5% | - | |
| Feb 16, 2024 | JNJ Johnson & Johnson | 10% Owner | Sale+OE | 3,725 | $25.81 | $96,142.25 | - | -1.5% | -0.3% | |
| Jun 30, 2020 | JNJ Johnson & Johnson | 10% Owner | Buy | 725,000 | $17.00 | $12,325,000.00 | +24.6% | - | - | |
| Nov 20, 2017 | JNJ Johnson & Johnson | 10% Owner | Sell | 18,367,346 | $2.75 | $50,510,201.50 | -100% | - | - | |
| Aug 16, 2016 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.3% | - | - | |
| Aug 11, 2015 | NGNE Neurogene Inc. | 10% Owner | Sell | 1,514,821 | $22.41 | $33,944,876.14 | -50.5% | - | - | |
| Jun 8, 2015 | JNJ Johnson & Johnson | 10% Owner | Sell | 1,010,265 | $47.94 | $48,432,104.10 | -32.8% | - | - |